2019 annual financial data
BioRestorative Therapies 2019 Operating margin
Direct answer
Operating margin was -6,486.16%.
Operating income was -8,432,005 USD and net income was -14,647,890 USD.
Operating cash flow was -6,918,734 USD.
Get free BioRestorative Therapies email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 130,000 USD
- Operating income
- -8,432,005 USD
- Net income
- -14,647,890 USD
- Operating cash flow
- -6,918,734 USD